P & G Health Ltd

{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,874.55",
    "chg": 52.95,
    "chgp": "1.1%",
    "dir": 1,
    "prev_price": "4,821.60",
    "mcapval": "7,995.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE199A01012",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "30.25 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs-4740-3893491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3893491.png",
        "date": "2026-03-16 10:32:24",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3892236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_mojoScore_3892236.png",
        "date": "2026-03-15 10:10:02",
        "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4781",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs4781-3879906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3879906.png",
        "date": "2026-03-09 12:02:34",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low today, with its stock price touching Rs.4781. This marks a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Procter & Gamble Health Ltd Falls to 52-Week Low of Rs.4824.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-to-52-week-low-of-rs482405-3873590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3873590.png",
        "date": "2026-03-05 12:22:54",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4824.05, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3869058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_mojoScore_3869058.png",
        "date": "2026-03-04 10:10:02",
        "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 March 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4845.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs484515-3864537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3864537.png",
        "date": "2026-03-02 11:19:49",
        "description": "Procter & Gamble Health Ltd’s share price declined to a fresh 52-week low of Rs.4845.15 today, marking a significant milestone in the stock’s recent performance. Despite a slight rebound after two consecutive days of falls, the stock remains below all key moving averages, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Procter & Gamble Health Ltd Stock Hits 52-Week Low Amidst Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-hits-52-week-low-amidst-market-downturn-3860499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ProcterGambleHe_priceRelatedfactors_3860499.png",
        "date": "2026-02-27 15:15:44",
        "description": "Procter & Gamble Health Ltd’s stock reached a fresh 52-week low of Rs.4872 today, marking a significant decline amid broader market weakness and company-specific performance factors. The stock has underperformed its sector and key benchmarks, reflecting a challenging period for the pharmaceuticals and biotechnology company."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3849409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ProcterGambleHe_mojoScore_3849409.png",
        "date": "2026-02-21 10:10:05",
        "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Why is Procter & Gamble Health Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-procter-gamble-health-ltd-fallingrising-3838717",
        "imagepath": "",
        "date": "2026-02-14 01:11:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Market Context</strong></p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 9.69% in value. On the day in question, it underperformed its sector by 2.53%, touching an intraday low of ₹4,959.40, which is just 1.2% above its 52-week low of ₹4,916. This proximity to the annual low signals significant investor caution. Furthermore, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish technical outlook.</p>\n<p>Investor participation has also waned, with delivery volumes on 12 Feb falling by 17.21% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm among shareholders, potentially ..."
      }
    ],
    "total": 144,
    "sid": "346859",
    "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": "Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited",
      "datetime": "06-Feb-2026",
      "details": "Dear Sir Please find attached communication in respect of deduction of TDS on the amount of dividend income from declaration of interim dividend for the Financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 6 2026",
      "datetime": "06-Feb-2026",
      "details": "We are enclosing herewith the following: a. Unaudited Financial Results; b. Limited Review Report in respect of the Unaudited Financial Results furnished by Statutory Auditors of the Company. Further we are pleased to inform you that the Board of Directors of the Company at its meeting held today inter alia have declared an Interim Dividend for the Financial Year 2025-26 of Rs. 160 per Equity Share (including a one-time special dividend of Rs. 50 per Equity Share). The dividend shall be paid on or before March 4 2026.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "06-Feb-2026",
      "details": "Board approves interim dividend of Rs. 160 (including one time special dividend of Rs. 50) per share.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>1100%</strong> dividend, ex-date: 12 Feb 26",
          "dt": "2026-02-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740

2026-03-16 10:32:24

Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-03-15 10:10:02

Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4781

2026-03-09 12:02:34

Procter & Gamble Health Ltd has reached a new 52-week low today, with its stock price touching Rs.4781. This marks a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Read full news article

Procter & Gamble Health Ltd Falls to 52-Week Low of Rs.4824.05

2026-03-05 12:22:54

Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4824.05, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-03-04 10:10:02

Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 March 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4845.15

2026-03-02 11:19:49

Procter & Gamble Health Ltd’s share price declined to a fresh 52-week low of Rs.4845.15 today, marking a significant milestone in the stock’s recent performance. Despite a slight rebound after two consecutive days of falls, the stock remains below all key moving averages, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Procter & Gamble Health Ltd Stock Hits 52-Week Low Amidst Market Downturn

2026-02-27 15:15:44

Procter & Gamble Health Ltd’s stock reached a fresh 52-week low of Rs.4872 today, marking a significant decline amid broader market weakness and company-specific performance factors. The stock has underperformed its sector and key benchmarks, reflecting a challenging period for the pharmaceuticals and biotechnology company.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-02-21 10:10:05

Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Why is Procter & Gamble Health Ltd falling/rising?

2026-02-14 01:11:34

Recent Price Movements and Market Context

The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 9.69% in value. On the day in question, it underperformed its sector by 2.53%, touching an intraday low of ₹4,959.40, which is just 1.2% above its 52-week low of ₹4,916. This proximity to the annual low signals significant investor caution. Furthermore, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish technical outlook.

Investor participation has also waned, with delivery volumes on 12 Feb falling by 17.21% compared to the five-day average. This decline in trading activity suggests reduced enthusiasm among shareholders, potentially ...

Read full news article

View All News